Avista Corp is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock looks fairly valued to slightly constrained near current levels, with neutral technicals, mixed analyst sentiment, and insider selling outweighing the modestly positive earnings beat. If the investor is impatient and wants to buy now rather than wait for a better entry, this is still not an attractive immediate purchase versus stronger opportunities.
AVA is trading at 40.98, essentially flat on the day, with price sitting just above pivot support at 40.836 and below near resistance at 41.435. RSI_6 at 52.8 is neutral, so momentum is not stretched in either direction. MACD histogram is -0.0641 and still negative, indicating mild bearish momentum even though it is contracting. Moving averages are converging, which usually signals a lack of a strong trend. The short-term pattern data suggests slight weakness over the next day and week, with only modest improvement over the next month. Overall, the technical setup is neutral to slightly cautious.

["Q1 2026 EPS of 1.11 beat expectations.", "Net income increased to 92 million from 79 million year over year.", "Gross margin improved to 52.11%", "Avista confirmed 2026 non-GAAP earnings guidance.", "Analyst price targets have edged higher at several firms, including Mizuho and Wells Fargo."]
["Revenue in Q1 2026 fell 7.62% year over year, which weakens the growth story.", "BofA still rates the stock Underperform and cited below-average earnings growth, regulatory lag, and a weaker regulatory backdrop.", "Insiders are selling, with selling activity up 195.50% over the last month.", "Hedge funds are neutral with no meaningful accumulation trend.", "Technical momentum remains weak with a negative MACD and no clear breakout signal."]
In Q1 2026, Avista delivered better profitability despite softer top-line results. Revenue declined to 570 million, down 7.62% year over year, but net income rose to 92 million, up 16.46%, EPS increased to 1.12, up 14.29%, and gross margin improved to 52.11%. This is a solid earnings quarter, but the revenue decline shows growth remains limited. For a long-term beginner investor, the quarter is more supportive of stability than of strong upside acceleration.
Recent analyst moves are mixed but slightly more constructive on price target levels, while ratings remain mostly neutral. Mizuho raised its target to 42 and stayed Neutral, Barclays lifted its target to 40 but kept Equal Weight, Wells Fargo raised to 39 and kept Equal Weight, and BofA raised to 37 but maintained Underperform. The overall Wall Street view is cautious: pros acknowledge stable utility characteristics and recent earnings strength, but the cons are more important here, including below-average earnings growth, regulatory risk, wildfire exposure, and limited upside versus peers. No significant politician or congress trading activity was reported.